Le Scienze Web News
Company developing innovative drug delivery systems (DDS) and products thereof. The company's platforms & products are patent protected and fit very well with the new evolving botanical drug industry.
The Company's proprietary platform technologies overcome major technological and economic obstacles for the development of a new generation of multi-functional, efficacious, safe and standardized botanical therapeutics.
The Company focuses its development and commercialization activities on unmet needs in four key target markets:
1.Ear (Otic) products.
2.Oral Care products.
3.Skin products.
4.Botanical granules for taste masking & controlled release
Some Products:
NATURAL EAR DROPS
JPMed has developed an alcohol-free unique vehicle for eardrops, comprising OGE (Oil-in-Glycerin Emulsion) which is solely made of permitted for human use pharmaceutical excipients and combination of therapeutic anti-bacterial, anti-fungal and anti-viral mixture of Essential oils.
Testimonial results of more than 20 patients revealed that pains are killed in 1-2 hours as compared to 12-24 hours with existing ear drops products. Moreover, within 24-48 hours the ear is free of inflammation.
A double blinded human clinical study is ongoing in one of the medical centers in Israel.
Aphta Gel(tm) CanKer Sores Treatment
AphtaGel(tm) Mouth Ulcer Gel - This is a product for the treatment of Canker Sores. The novel product is registered in Israel as a device. Testimonials revealed its efficacy and patient friendly application.
Launch in Israel is planned for the 3rd quarter of this year. Based on future available resources, the company plans to pursue registration of this product in the USA as a botanical drug.
Medicphar-J3
E-mail: info [AT] medicphar.biz
Make a donation
